Respiratory diseases like asthma, acute respiratory syndrome (ARDS), chronic obstructive
respiratory disease (COPD), and lung cancer are imposing a burden on the aging …

Tremendous advancements in nanotechnology have contributed to the development of
'smart'nanoparticle systems that can effectively transport a drug to the desired site of release …

Respiratory diseases, both acute or chronic and infectious or non-infectious, affect millions
of people worldwide. The leading causes of morbidity and mortality due to respiratory …

Exosomes are membrane-derived extracellular vesicles with an average diameter of 30-200
nanometers that are generated by budding of plasma and endosome membranes. They …

To explore the role of extracellular vesicles (EVs) in chronic lung diseases. EVs are
emerging as mediators of intercellular communication and possible diagnostic markers of …

Chronic respiratory diseases include chronic obstructive pulmonary disease (COPD),
pulmonary tuberculosis, idiopathic pulmonary fibrosis (IPF), cystic fibrosis, asthma, and lung …

Medicinal plants have been utilized to treat a variety of conditions on account of the
bioactive properties that they contain. Most bioactive constituents from plants are of limited …

For treatment of human diseases, nasal and pulmonary routes of drug delivery are gaining
increasing importance. These routes provide promising alternatives to parenteral drug …

The rapid and non-invasive pulmonary drug delivery (PDD) has attracted great attention
compared to the other routes. However, nanoparticle platforms, like liposomes (LPs) and …

Bioinspired (or biologically inspired) drug delivery systems (DDSs) have been intensively
studied in the last decades. As bioinspired DDSs, membrane vesicles, including …